Dec 8, 2022
Do combined, multi constituent products which contain more than one chemical, such as Levodopa + Carbidopa + Entacapone Tabs, suffer slower price decay after generic launch than normal single constituent products? It would make sense to assume so as we have previously...
Dec 2, 2022
Are products which have received concessions (NCSOs) from the department of health and social care (DHSC) less profitable than non-concession receiving products? After Viatris’ round table on branded generics at the Palace of Westminster earlier this month we...
Nov 22, 2022
Where pharmacies are unable to purchase generic products at prices less than the drug tariff the DHSC sets price concessions in consultation with the PSNC using information derived from manufacturers and wholesalers. The number of price concessions granted in each...
Nov 17, 2022
Branded generics as well as originator brands are included in the VPAS (The Voluntary Scheme for Branded Medicines Pricing and Access) reimbursement scheme. This is agreed by Government, NHS and industry to ensure the consistent and affordable supply of branded...
Nov 2, 2022
In recent years branded generics, which are branded versions of off-patent medicines other than the originator, have been included in the VPAS Voluntary Scheme for Branded Medicines Pricing. This has meant that the manufacturers of branded generics have had to return...
Oct 26, 2022
Rasagiline Tabs 1mg 28 was launched onto the UK market as a new generic in August 2015 and since then has had three periods of shortage, during which prices have risen and concessions have been granted by the DHSC to improve supply and pharmacy profitability. These...
